Anti-Obesity Drug Linked To 5 Deaths In U.K.
Acomplia, the Sanofi-Aventis SA anti-obesity drug rejected by the U.S. Food and Drug Administration last year due to fears of psychiatric side effects, has been linked to five deaths, including one...To view the full article, register now.
Already a subscriber? Click here to view full article